MeSH tree: D20
Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new European study has shown that carefully designed observational studies can produce robust and reliable ...
Mar 17, 2026
0
12
People with heart disease who received a shingles vaccine had nearly half the rate of serious cardiac events a year later compared with those who did not get the vaccine, according to a study being presented at the American ...
Mar 17, 2026
0
17
The American College of Physicians (ACP) is warning that recent federal changes to introduce a new, more limited vaccination schedule for U.S. children based on the Danish childhood vaccine schedule abandons long-standing, ...
Mar 16, 2026
0
3
When 12-year-olds receive a letter from the school nurse about the HPV vaccine, their reactions are often mixed. Some students worry about the needle. Others wonder why they need a vaccine for something they have never heard ...
Mar 16, 2026
0
8
Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the Centers for Disease Control. But the field of cancer vaccines, which can be used as a form of treatment, ...
Mar 16, 2026
0
17
Biomaterials are specifically engineered to support tissue, nerve and muscle regeneration across the body, yet physicians and researchers have limited control over the size and connectivity of the internal pores that transfer ...
Mar 14, 2026
0
12
In the three decades between 1993 and 2024, measles in the U.S. was relatively rare—a few hundred cases each year, at most. But suddenly, the disease has become so entrenched in American life that it sometimes fails to make ...
Mar 12, 2026
0
7
Malaria is caused by a parasite that is spread to humans by infected mosquitoes. In 2024, almost 282 million people worldwide were infected and 610,000 died, according to the World Health Organization. Malaria is a leading ...
Mar 11, 2026
0
25
In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a five-year period. The results ...
Mar 11, 2026
0
19
T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can't easily distinguish cancerous T cells from healthy ones. Now, scientists ...
Mar 10, 2026
0
18
